Form 4 for SNTI Senti Biosciences Holdings, Inc.

Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-10 · accession 0001079973-25-000394 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-03-14	2025-03-10	SNTI	Celadon Partners SPV 24	10%	C - Cnv Deriv	—	+9.78M	9.78M	New	—
D	2025-03-14	2025-03-10	SNTI	Celadon Partners SPV 24	10%	C - Cnv Deriv	—	-9,777	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-03-10	C	A	9,777,000	—	9,777,000	D	—	—	(F1) Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date.
2	Derivative	Series A Convertible Preferred Stock	2025-03-10	C	D	9,777	—	0	D	— · — to —	9,777,000 Common Stock	(F1) Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date.